youtube_live
Mapato ya Q3 2026 • imetolewa • Imepitisha kiasi cha mapato kwa hisa +11.45% • Kiasi kilichotarajiwa cha mapato kimezidi +3.01%
Angalia matokeochevron_right
AMG:ETR
Amgen Inc
€ 413.85
arrow_downward
-1.03%(-4.30) Siku 1
6 Nov, 17:35:34 GMT +1 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya AMG...
Fungua
€ 409.60
Juu
€ 414.60
Chini
€ 401.65
Mtaji wa soko
249.09B
Wastani wa kiasi cha mauzo
520.00
Kiasi cha mauzo ya hisa
959.00
Juu kwa wiki 52
€ 438.75
Chini kwa wiki 52
€ 267.60
Idadi ya wafanyakazi
elfu 32
Fungua
€ 409.60
Juu
€ 414.60
Chini
€ 401.65
Mtaji wa soko
249.09B
Wastani wa kiasi cha mauzo
520.00
Kiasi cha mauzo ya hisa
959.00
Juu kwa wiki 52
€ 438.75
Chini kwa wiki 52
€ 267.60
Idadi ya wafanyakazi
elfu 32
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Yahoo Finance
·
dakika 55 zilizopita
Amgen’s Dividend Has Grown 800% Since 2011. Here’s What It Pays Today
Investing.com
·
siku 2 zilizopita
Freedom Broker downgrades Amgen stock rating on valuation despite raising price target
GuruFocus
·
siku 2 zilizopita
Amgen Inc (AMGN) Shares Fall 3.8% -- GF Value Says Still Overval
MarketWatch
·
siku 2 zilizopita
Amgen Inc. stock underperforms Thursday when compared to competitors
Wasifu
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Kuhusu Amgen Inc
Afisa Mkuu Mtendaji (CEO)Robert A. Bradway
Wafanyakazielfu 31.5
Lilianzishwa1980
Makao makuuThousand Oaks, California, Marekani
SektaHealth Care
Sekta-
Tovutiamgen.com